1
Schols, Angel M. R., Meijs, Eline, Dinant, Geert-Jan, Stoffers, Henri E. J. H., Krekels, Marielle M. E., Cals, Jochen W. L.
Veröffentlicht in: Schols , A M R , Meijs , E , Dinant , G-J , Stoffers , H E J H , Krekels , M M E & Cals , J W L 2019 , ' General practitioner use of D-dimer in suspected venous thromboembolism : historical cohort study in one geographical region in the Netherlands ' , BMJ Open , vol. 9 , no. 5 , 026846 . https://doi.org/10.1136/bmjopen-2018-026846;
2019
Veröffentlicht in: Schols , A M R , Meijs , E , Dinant , G-J , Stoffers , H E J H , Krekels , M M E & Cals , J W L 2019 , ' General practitioner use of D-dimer in suspected venous thromboembolism : historical cohort study in one geographical region in the Netherlands ' , BMJ Open , vol. 9 , no. 5 , 026846 . https://doi.org/10.1136/bmjopen-2018-026846;
2019
2
de Jong, Lisa A, Dvortsin, Evgeni, Janssen, Kristel J., Postma, Maarten J.
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017
3
Heisen, Marieke, Treur, Maarten J, Heemstra, Harald E, Giesen, Eric B W, Postma, Maarten J
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017